ARTICLE | Distillery Therapeutics
Cancer
January 31, 2017 11:06 PM UTC
Patient sample and mouse studies suggest inhibiting CD99 could help treat AML and MDS. Levels of CD99 were higher in hematopoietic stem cells (HSCs) from MDS patients and blasts from AML patients than...
BCIQ Company Profiles
BCIQ Target Profiles